Literature DB >> 25279171

Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).

Christopher B Owen1, David J Hughes1, Belinda Baquero-Perez1, Anja Berndt1, Sophie Schumann1, Brian R Jackson1, Adrian Whitehouse1.   

Abstract

The γ-herpesviruses Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus are successful pathogens, each infecting a large proportion of the human population. These viruses persist for the life of the host and may each contribute to a number of malignancies, for which there are currently no cures. Large-scale proteomic-based approaches provide an excellent means of increasing the collective understanding of the proteomes of these complex viruses and elucidating their numerous interactions within the infected host cell. These large-scale studies are important for the identification of the intricacies of viral infection and the development of novel therapeutics against these two important pathogens.

Entities:  

Keywords:  mass spectrometry; proteomics; γ-herpesvirus

Year:  2014        PMID: 25279171      PMCID: PMC4179824          DOI: 10.3892/mco.2014.341

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  128 in total

Review 1.  Detection technologies in proteome analysis.

Authors:  Wayne F Patton
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-05-05       Impact factor: 3.205

2.  Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry.

Authors:  Pavel V Bondarenko; Dirk Chelius; Thomas A Shaler
Journal:  Anal Chem       Date:  2002-09-15       Impact factor: 6.986

3.  Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin.

Authors:  A Szebeni; B Mehrotra; A Baumann; S A Adam; P T Wingfield; M O Olson
Journal:  Biochemistry       Date:  1997-04-01       Impact factor: 3.162

4.  Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.

Authors:  Michael Pearce; Satoko Matsumura; Angus C Wilson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

6.  SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function.

Authors:  Marcus Krüger; Markus Moser; Siegfried Ussar; Ingo Thievessen; Christian A Luber; Francesca Forner; Sarah Schmidt; Sara Zanivan; Reinhard Fässler; Matthias Mann
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 7.  Proteomics for understanding miRNA biology.

Authors:  Tai-Chung Huang; Sneha M Pinto; Akhilesh Pandey
Journal:  Proteomics       Date:  2012-12-27       Impact factor: 3.984

8.  Highly multiplexed and strand-specific single-cell RNA 5' end sequencing.

Authors:  Saiful Islam; Una Kjällquist; Annalena Moliner; Pawel Zajac; Jian-Bing Fan; Peter Lönnerberg; Sten Linnarsson
Journal:  Nat Protoc       Date:  2012-04-05       Impact factor: 13.491

9.  Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome.

Authors:  Nazzarena Labo; Wendell Miley; Vickie Marshall; William Gillette; Dominic Esposito; Matthew Bess; Alexandra Turano; Thomas Uldrick; Mark N Polizzotto; Kathleen M Wyvill; Rachel Bagni; Robert Yarchoan; Denise Whitby
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

10.  A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells.

Authors:  Brian R Jackson; Marko Noerenberg; Adrian Whitehouse
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

View more
  1 in total

1.  ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.

Authors:  Jennifer J Wood; James R Boyne; Christina Paulus; Brian R Jackson; Michael M Nevels; Adrian Whitehouse; David J Hughes
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.